chrisvoncsefalvay/vaers-outcomes huggingface dataset:
in early March I began having pulsatile tinnitus episodes... a couple of day. Not long after I experienced heart palpitations. I didn't initially think of the vaccine. However, after my second vaccine, the pulsatile tinnitus was continuing, but the heart palpitations were most concerning at about 7 or 8 a day. This went on until late April. I went to my Doctor's office about mid-April and an ECG showed nothing wrong. and I then presented at ER on the evening of the 26th as I was concerned about their frequency. Many tests were conducted and it showed nothing wrong with my heart and we could not simulate the random heart palpitations at the time.   The palpitations resolved early May and I have had only a handful of tinnitus episodes since.
The patient had been in the post vaccine area close to 15 minutes. The patient said it felt like she could feel the vaccine going thru her arm and across her face and up the side of her face and she felt a little dizzy.  I asked her if she wanted a water and I would check on her in 5 minutes.  She then said her tongue felt a little funny, but that she could swallow. I had her wait approximately 15 minutes longer to see if it would pass.  She stated that the dizziness had passed but the tongue/throat felt a little swollen but it had not progressed.  There was no redness/flushing.  I offered her a dose of Benadryl. Pt accepted the dose.  I asked her to call me when she arrived at her destination.  The patient called to say that she had arrived and was feeling some better.
pt recv vax & pt devel varicella on buttocks, knees, around mouth 1 lesion in mouth;
I had a kidney stone. I had pain and had to go to the ER on July 7th. This is the first time I have ever had a kidney stone.
Immediately upon receiving the shot I felt pain behind my left ear.  It continued throughout the next day whereupon I also started experiencing numbness on the left side of my face similar to getting a shot of Novocaine at the dentist.  As each day passed, the symptoms kept progressing across my face until my mouth is permanently skewed to the right.  It makes eating, drinking and speaking difficult.  Coincidentally the day after my vaccination, I had an appointment on Friday, March 12 at 10:30am for my first appointment with my new doctor.  I mentioned the ear pain (the numbness didn't start until that same afternoon) and she mentioned it wasn't uncommon for the lymph glands to be affected by the vaccination.  I assumed my symptoms would go away in a few days.  When they kept getting more pronounced, I sent her a couple of emails but she was out of the office until Tuesday, March 16.  Her assistant contacted me on Tuesday the 16th and told me to call 911 and go to the emergency room.  I drove myself to the Medical Group emergency room and was seen by the Dr.  After examining me, she also consulted with a neurologist and they diagnosed me with bell's palsy and said it would take between six to eight months to self correct.  She prescribed me Predisone 20mg dosage of three tablets once a day and Valacyclovir 1 gram dosage three times a day.  She also suggested I get some eye ointment to use at night and eye drops to be used four times a day since my left eye doesn't close all the way now.
pt broke out in hives p/vax given;hives went away p/3-4hr;no other s/s noted by mom;
When she woke up from her nap, she wasn't walking well, really limping, her leg was quite swollen and she was very agitated. By bedtime (7pm) we had to carry her everywhere. At 7:30PM I called the doctor's office. They advised me to give her some Motrin to help her sleep and this was a mild reaction.
This spontaneous report was received from registered nurse via a company representative and refers to a 19 year old female patient. On an unknown date the patient was vaccinated with GARDASIL 9 (dose, frequency, route of administration, lot # and expiration date not reported). On an unknown date, after receiving GARDASIL 9, she had "sx". The reporter did not know what the "sx" represented. The outcome of adverse event was unknown. The relatedness between the event and GARDASIL 9 was not reported. Additional information has been requested.
Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Nausea-Mild
First does Sun Oct 30 at 7:30 pm. No reaction.  Second dose Tuesday Oct 31 at 7:30 pm.  At 8:45 pm the inside of both thighs had hives and itched.  He went to bed and woke in the morning at 5:45 am to no hives on his legs but hives on both forearms and both tops of his feet.
Patient passed out about 5 minutes after receiving the vaccine. He was seated in a chair right outside of the pharmacy and fell and hit his head. He said shortly after receiving the vaccine he felt nervous (he normally is nervous with needles he said) and then passed out. He did say that this has happens with almost every vaccine he has received throughout his life, so he was not surprised that it occurred. 911 was called and paramedics came to assess him due to the fall. He denied shortness of breath, trouble breathing, and any other symptoms.
Fever took Tylenol Very tired Starting spotting lightly was 10 weeks  pregnant The spotting became like a period Labor contractions  Miscarried at 12 weeks
Fever, body aches for 1-2 days with light sensitivity, headache. Light sensitivity and headaches, fatigue, muscle pain, joint pain for months following.
Received vaccines Monday evening. Egg free flu vaccine given due to history of egg allergy/pt request. Late that night and next AM developed arm pain, red rash on arm where she received vaccine, diarrhea. Began ~12 hours post administration. Pertinent negatives include no coughing, difficulty breathing, drooling, eye itching, eye redness, eye watering, hyperventilation, itching, trouble swallowing, vomiting or wheezing. Swelling location: At injection site, none in face/mouth.
1st dose 01OCt2020, 2nd 26Jan2023; This non-serious case was reported by a consumer and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose on 1st October 2020).   On 26-JAN-2023, the patient received the 2nd dose of Shingrix. On 26-JAN-2023, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: 1st dose 01OCt2020, 2nd 26Jan2023). The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK receipt date: 29-Mar-2023 The patient asked that he/she should get another dose to be safe. The patient received 2nd dose of Shingrix later than the recommended interval, which led to lengthening of vaccine schedule.
Pain, fever, swelling, hard knot at injection site, chest pressure, shortness of breath, throat feel like it was swelling shut, cough, difficulty talking. The chest pressure began Sunday morning and readily got worse eventually resulting to a trip to the ER when Benadryl, rescue inhaler, and EPI pen didn?t work.
This spontaneous report as received from a health professional (certified Medical Assistant) refers to an unspecified number of patients of unknown age and gender. The reporter stated that an unspecified number of doses of PNEUMOVAX 23, 0.5 ml (route, Lot# and expiration date were not reported), which underwent a supported temperature excursion, may have been administered to unspecified patients on unspecified dates. No adverse experiences reported. It was unknown if the patients sought medical attention. Additional information is not expected, because the physician can not be contacted.
dizziness; sore arm for some time; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm for some time) and DIZZINESS (dizziness) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm for some time). In February 2021, the patient experienced DIZZINESS (dizziness). At the time of the report, PAIN IN EXTREMITY (sore arm for some time) had resolved and DIZZINESS (dizziness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. No relevant concomitant medications were reported.
tested positive for covid 19 but had no symptoms; they gave him half a dose of his first Pfizer-BioNTech COVID-19 vaccine; This is a spontaneous report from a contactable consumer reported for father. A 64-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. Caller stated her 64-year-old father was told by the vaccination provider that they gave him half a dose of his first Pfizer-BioNTech COVID-19 vaccine, because he was on blood thinners. She added the next day, which was a Friday, they had to go test for COVID-19 because of her mother who tested positive and he father also tested positive but has no symptoms. She asked do people on blood thinner get half a dose of the vaccine. Caller asked if getting the first dose of the Pfizer-BioNTech COVID-19 vaccine while being infected with COVID-19 would cause an impact on the vaccine. She specified she thought her father might have had COVID-19 the day he got the vaccine. The outcome of the event was unknown. Information on the Lot/batch number has been requested.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the reporter reiterated  that because her facility was unable to download  they would need to treat this issue as a temperature excursion. The data  was unable to download for the months of Dec 2021, Jan 2022, and Feb 2022. It was reported that the patients have been administered doses while the temperature excursion assessment was ongoing and reported that no adverse reactions were reported by any patients.  No treatment information reported.
Within minutes of receiving vaccine, mother reports she noted erythema & swelling at immunization site on right thigh of approx 1/2 inch. Within 24hours, erythema & swelling increased to 1.5 inches. Within 48 hours, erythema & swelling increased to 4.5 inches. Now (~72 hours) improved with approx 4 in area of erythema & no swelling.
pt recv vax & became preg LMP 7/10/97 & pt devel hemorrhoids date unk;
after first Covid vaccine - very sore arm but that's it. After second, listed her, 12 hours after injection, sore arm, 102 fever, severe had and neck ache, chills, abdominal discomfort, heart palpitations. All of the above lasted for over 48 hours then developed large swollen lymph node under left arm pit (same as got shot). 13 days after receiving the second vaccine, heart palpitations, extreme vertigo/dizziness, confusion, facial flushing and blood shot eyes. I am on day 13 now, pretty afraid b/c I have never experienced these kind of symptoms before. I have a call into my physician.
Initial and follow-up information has been received from a registered nurse concerning a 5 year old male with no relevant medical history or allergies who on 02-JUL-2008 was vaccinated with a 0.5 ml dose of VARIVAX (Merck) (lot number 660282/1897U) subcutaneously in the left deltoid, and a dose of MMR (MSD) subcutaneously in the right deltoid. There was no concomitant medication. On approximately 04-JUL-2008, also reported as 2 days later, the patient experienced abdominal pain. The pain persisted and he awakened at night crying from the pain. The patient was given MOTRIN for the discomfort, results are not known. The patient did not experience any nausea, vomiting, diarrhea, or constipation. On 09-JUL-2008, it was confirmed that the patient had mesentery adenitis. On 10-JUL-2008, laboratory tests were performed which showed that platelet count and serum albumin abnormal. Abdominal ultrasound showed that "matted lymph nodes in the right lower quadrant and periumbilical area. Finding may be consistent with mesentery adenitis." Unspecified medical attention was sought. At the time of reporting, the outcome of the patient was unknown. Additional information is not expected.
Patient states he had a temperature of 103 the next day (Saturday) and resolved by Monday 10/28/02
Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
progressive ascending weakness w/paralysis of both lower extremities;extreme leg pain, burning feet, upper body weakness w/mild resp difficulties /in 6hr post vax sx began;dx GBS;polyneuropathy;60 day follow-up no additional data.Annual follow-up states pt is unable to return to work in any capacity. The pt suffers from many poly and mononeuropathies that interfere with his activities of daily living. He has a gait disturbance and is prone to falls.
Light period started on December 20. This was two weeks earlier than the normal start of my menstrual cycle. I have had light bleeding for 2+ weeks at this point.
Fever up to 101, chills with rigors, body aches, headache, nausea lasting about 24 hours
bradycardia during feeding progressing to cardiorespiratory arrest;resuscitated & on ventilator;
Joint swelling and pain. Areas affected bilateral hips and shoulders, and lumbar. States pain level 7-8. Received vaccination on Thursday 1/7/2021 at 3pm and symptoms started when he woke up on Friday morning 1/8/2021.
body aches; Sore joints; chills; injection site soreness; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 14May2021 at 14:30 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included vitamin d nos (VITAMIN D), fish oil (MANUFACTURER UNKNOWN), iron (MANUFACTURER UNKNOWN) and unspecified prenatal vitamins; all for unspecified indications from unknown date. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 23Apr2021 at 09:15 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and albuterol (MANUFACTURER UNKNOWN); both for unspecified indication from unknown date  and experienced drug allergy to both. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 07:30, the patient experienced sore joints, body aches, chills and injection site soreness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the event sore joints, body aches, chills and injection site soreness was recovered on an unknown date of May2021.   No follow-up attempts are needed. No further information is expected.
Redness and swelling at injection site. Not completely resolved but improved as of 01/04/2002.
Blood pressure spike to 180/110 within 15 minutes of being administered first dose of Pfizer Covid-19 Vaccine on 1/21/21. Observed by attending physician while resting reclined with head elevated. Provided hydration (water). Elevated blood pressure began to decline within 30 minutes thereafter. Was able to drive home. Have since been suffering with mild to moderate sinus headaches and stiffness in the joints of my hands/fingers on both left and right hands. Ears occasionally clogged. Taking Tylenol and Flonase.
fatigue, muscle aches, fever/sweats, drop in breastmilk (breastfeeding mom that is pumping)
it felt different and she noticed tracks like shingles from her back to her stomach with blisters forming.; diagnosed with shingles; Backache; developed a backache that felt like a sore muscle which grew worse until Sunday night; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (diagnosed with shingles), BLISTER (it felt different and she noticed tracks like shingles from her back to her stomach with blisters forming.), BACK PAIN (Backache) and MYALGIA (developed a backache that felt like a sore muscle which grew worse until Sunday night) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Varicella zoster vaccine (10 years ago). Past adverse reactions to the above products included No adverse event with Varicella zoster vaccine.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced BACK PAIN (Backache) and MYALGIA (developed a backache that felt like a sore muscle which grew worse until Sunday night). On 21-Mar-2021, the patient experienced HERPES ZOSTER (diagnosed with shingles). On an unknown date, the patient experienced BLISTER (it felt different and she noticed tracks like shingles from her back to her stomach with blisters forming.). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) at an unspecified dose and frequency; GABAPENTIN at an unspecified dose and frequency and HYDROCODONE at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (diagnosed with shingles), BLISTER (it felt different and she noticed tracks like shingles from her back to her stomach with blisters forming.), BACK PAIN (Backache) and MYALGIA (developed a backache that felt like a sore muscle which grew worse until Sunday night) had not resolved.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported.  Follow-up received on x date included no new information   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: No new information was reported
45-year-old male follow-up from the ER. He received a COVID-19 vaccine on 1/22/2021. This was his first dose. He began having bilateral lower extremity pain the following evening. In addition to the pain, he has been dealing with headaches, dizziness, auditory hallucinations, and large areas of redness and warmth on the left upper extremity and bilateral lower extremities. He went to the ER on 1/27/2021. Upon review of those records, he had microscopic hematuria. The patient states that he passed some kidney stones this week. Other abnormal labs include very elevated liver enzymes which the patient has not had before. He does not drink any alcohol. No new medications. He also had thrombocytopenia.  O) Gen: Patient is in a wheelchair during today's exam. This is the first time he ever been in the exam room in a wheelchair. He required assistance to stand up. He says the pain is what makes it so difficult to stand up.  Skin: On the left forearm, there is a large area of redness and swelling. The redness is relatively faint. On the lateral aspect of the right thigh, there is a large area of redness and swelling which is more prominent.  ASSESSMENT 1. Severe myalgias 2. Elevated liver enzymes 3. Thrombocytopenia  PLAN 1. Check sed rate and CRP. 2. Recheck CMP along with viral hepatitis panel and lipase. 3. Recheck CBC with differential. 4. Further recommendations based on these results.  ADDENDUM Patient called on 2/1/2021 and reports his pain is getting worse to such an extent that he has been unable to make it to the bathroom fast enough and has been having accidents.
Initial misuse report received from a healthcare professional on 05 September 2013. A 77-years-old female patient received ADACEL. This vaccine is only approved up to age 64 years patient. No other information was provided regarding the patient. No adverse event was reported. List of documents held by sender: none.
Only had aches for the first days; A spontaneous report was received from a consumer concerning his cousin, of an unspecified age and gender, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced aches for the first days / pain. The patient's medical history was not provided. No relevant concomitant medications were reported. On an unknown date, prior to the onset of the event, the patient received their planned doses of mRNA-1273 (Lot number: unknown) for prophylaxis of COVID-19 infection. The route of administration and dose number was not provided.  On an unknown date post vaccination, the patient had aches for the first days.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the event was unknown.
I had flu like symptoms. I had a massive headache that still hasn't gone away. I was very weak and light headed about ten hours after the injection. I had chills that turned into a fever and it last about 24 hours. In addition, the injection site was hot to the touch for two days.